Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs.

Liu M, Wu Y, Chen Y, Sun J, Zhao Z, Chen XW, Matheny ME, Xu H.

J Am Med Inform Assoc. 2012 Jun;19(e1):e28-35.

2.

Systematic analysis of the associations between adverse drug reactions and pathways.

Chen X, Wang Y, Wang P, Lian B, Li C, Wang J, Li X, Jiang W.

Biomed Res Int. 2015;2015:670949. doi: 10.1155/2015/670949. Epub 2015 Oct 1. Review.

3.

Methods and systems to detect adverse drug reactions in hospitals.

Thürmann PA.

Drug Saf. 2001;24(13):961-8. Review.

PMID:
11735652
4.

In silico assessment of adverse drug reactions and associated mechanisms.

Ivanov SM, Lagunin AA, Poroikov VV.

Drug Discov Today. 2016 Jan;21(1):58-71. doi: 10.1016/j.drudis.2015.07.018. Epub 2015 Aug 10. Review.

PMID:
26272036
5.

Improving drug safety: From adverse drug reaction knowledge discovery to clinical implementation.

Tan Y, Hu Y, Liu X, Yin Z, Chen XW, Liu M.

Methods. 2016 Nov 1;110:14-25. doi: 10.1016/j.ymeth.2016.07.023. Epub 2016 Jul 30. Review.

PMID:
27485605
6.

Advances in machine learning prediction of toxicological properties and adverse drug reactions of pharmaceutical agents.

Ma XH, Wang R, Xue Y, Li ZR, Yang SY, Wei YQ, Chen YZ.

Curr Drug Saf. 2008 May;3(2):100-14. Review.

PMID:
18690988
7.

Adverse drug reactions: a review of relevant factors.

Ajayi FO, Sun H, Perry J.

J Clin Pharmacol. 2000 Oct;40(10):1093-101. Review.

PMID:
11028248
8.

[Management of adverse drug effects].

Schlienger RG.

Ther Umsch. 2000 Sep;57(9):584-90. Review. German.

PMID:
11036440
9.

The role of reactive drug metabolites in immune-mediated adverse drug reactions.

Hess DA, Rieder MJ.

Ann Pharmacother. 1997 Nov;31(11):1378-87. Review.

PMID:
9391694
10.

[Analysis of drug safety information using large-scale adverse drug reactions database].

Morikawa K.

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2011;(129):1-26. Review. Japanese.

PMID:
22259840
11.

Data-driven Approach to Detect and Predict Adverse Drug Reactions.

Ho TB, Le L, Thai DT, Taewijit S.

Curr Pharm Des. 2016;22(23):3498-526. Review.

PMID:
27157416
12.

Adverse drug reactions - allergy? side-effect? intolerance?

Smith W.

Aust Fam Physician. 2013 Jan-Feb;42(1-2):12-6. Review.

13.

Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms.

Boland MR, Jacunski A, Lorberbaum T, Romano JD, Moskovitch R, Tatonetti NP.

Wiley Interdiscip Rev Syst Biol Med. 2016 Mar-Apr;8(2):104-22. doi: 10.1002/wsbm.1323. Epub 2015 Nov 12. Review.

14.

Pharmacogenomics of Off-target ADRs.

Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA, Phillips EJ.

Br J Clin Pharmacol. 2017 Mar 26. doi: 10.1111/bcp.13294. [Epub ahead of print] Review.

PMID:
28345177
15.

Prediction of Metabolism of Drugs using Artificial Intelligence: How far have we reached?

Kumar R, Sharma A, Siddiqui MH, Tiwari RK.

Curr Drug Metab. 2016;17(2):129-41. Review.

PMID:
26526829
16.

Post-marketing surveillance of the quinolones: a view from Great Britain.

Davey PG.

Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1402-7. Review.

PMID:
2672260
17.

Analysis of the adverse reactions induced by natural product-derived drugs.

Zeng ZP, Jiang JG.

Br J Pharmacol. 2010 Apr;159(7):1374-91. doi: 10.1111/j.1476-5381.2010.00645.x. Epub 2010 Mar 3. Review.

18.

In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Elzagallaai AA, Rieder MJ.

Br J Clin Pharmacol. 2015 Oct;80(4):889-900. doi: 10.1111/bcp.12505. Epub 2015 Jun 1. Review.

19.

Emerging RNA editing biomarkers will foster drug development.

van der Laan S, Salvetat N, Weissmann D, Molina F.

Drug Discov Today. 2017 Feb 7. pii: S1359-6446(17)30068-5. doi: 10.1016/j.drudis.2017.01.017. [Epub ahead of print] Review.

PMID:
28188894

Supplemental Content

Support Center